	Dec'05	Dec'06	Dec'07	Dec'08	Dec'09	Dec'10	Dec'11	Dec'12	Dec'13	Dec'14	Dec'15	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24
Revenue % growth	12,430.0 17.8%	14,268.0 14.8%	14,771.0 3.5%	15,003.0 1.6%	14,642.0 (2.4%)	15,053.0 2.8%	15,582.0 3.5%	17,265.0 10.8%	18,676.0 8.2%	20,063.0 7.4%	21,662.0 8.0%	22,991.0 6.1%	22,849.0 (0.6%)	23,747.0 3.9%	23,362.0 (1.6%)	25,424.0 8.8%	25,979.0 2.2%	26,323.0 1.3%	28,190.0 7.1%	33,424.0 18.6%
Cost of Goods Sold (COGS)	2,082.0	2,095.0	2,548.0	2,296.0	2,091.0	2,220.0	2,427.0	2,918.0	3,346.0	4,422.0	4,227.0	4,162.0	4,069.0	4,101.0	4,356.0	6,159.0	6,454.0	6,406.0	8,415.0	12,858.0
Gross Profit % margin	10,348.0 83.3%	12,173.0 85.3%	12,223.0 82.7%	12,707.0 84.7%	12,551.0 85.7%	12,833.0 85.3%	13,155.0 84.4%	14,347.0 83.1%	15,330.0 82.1%	15,641.0 78.0%	17,435.0 80.5%	18,829.0 81.9%	18,780.0 82.2%	19,646.0 82.7%	19,006.0 81.4%	19,265.0 75.8%	19,525.0 75.2%	19,917.0 75.7%	19,775.0 70.1%	20,566.0 61.5%
Operating Expenses	5,500.0	7,102.0	7,444.0	7,493.0	7,045.0	7,288.0	8,843.0	8,770.0	9,463.0	9,450.0	8,965.0	9,035.0	8,807.0	9,383.0	9,332.0	10,126.0	10,381.0	10,351.0	11,878.0	13,308.0
Research & Development Expenses (R&D)	2,314.0	3,366.0	3,266.0	3,030.0	2,864.0	2,894.0	3,167.0	3,380.0	4,083.0	4,297.0	4,070.0	3,840.0	3,562.0	3,737.0	4,116.0	4,207.0	4,819.0	4,434.0	4,784.0	5,964.0
Selling, General & Administrative Expenses (SG&A)	2,790.0	3,366.0	3,361.0	3,789.0	3,820.0	3,983.0	4,486.0	4,801.0	5,184.0	4,699.0	4,846.0	5,062.0	4,870.0	5,332.0	5,150.0	5,730.0	5,368.0	5,414.0	6,179.0	7,096.0
Operating Income % margin	4,848.0 39.0%	3,840.0 26.9%	3,980.0 26.9%	5,214.0 34.8%	5,506.0 37.6%	5,545.0 36.8%	4,312.0 27.7%	5,577.0 32.3%	5,867.0 31.4%	6,191.0 30.9%	8,470.0 39.1%	9,794.0 42.6%	9,973.0 43.6%	10,263.0 43.2%	9,674.0 41.4%	5,794.0 22.8%	6,005.0 23.1%	5,335.0 20.3%	7,897.0 28.0%	7,258.0 21.7%
Interest Income	0.0	0.0	0.0	145.0	276.0	376.0	448.0	485.0	420.0	465.0	603.0	629.0	928.0	674.0	753.0	256.0	1,197.0	1,406.0	0.0	0.0
Interest Expense	29.0	2,282.0	2,136.0	344.0	578.0	604.0	610.0	1,053.0	1,022.0	1,071.0	1,095.0	1,260.0	1,304.0	1,392.0	1,289.0	1,262.0	1,197.0	1,406.0	2,875.0	3,155.0
Pre-tax Income	4,868.0	4,020.0	3,961.0	5,250.0	5,204.0	5,317.0	4,150.0	5,009.0	5,265.0	5,585.0	7,978.0	9,163.0	9,597.0	9,545.0	9,138.0	8,133.0	6,701.0	7,346.0	7,855.0	4,609.0
Income Tax % effective tax rate	1,194.0 24.5%	1,070.0 26.6%	795.0 20.1%	1,054.0 20.1%	599.0 11.5%	690.0 13.0%	467.0 11.3%	664.0 13.3%	184.0 3.5%	427.0 7.6%	1,039.0 13.0%	1,441.0 15.7%	7,618.0 79.4%	1,151.0 12.1%	1,296.0 14.2%	869.0 10.7%	808.0 12.1%	794.0 10.8%	1,138.0 14.5%	519.0 11.3%
Net Income % margin	3,674.0 29.6%	2,950.0 20.7%	3,166.0 21.4%	4,196.0 28.0%	4,605.0 31.5%	4,627.0 30.7%	3,683.0 23.6%	4,345.0 25.2%	5,081.0 27.2%	5,158.0 25.7%	6,939.0 32.0%	7,722.0 33.6%	1,979.0 8.7%	8,394.0 35.3%	7,842.0 33.6%	7,264.0 28.6%	5,893.0 22.7%	6,552.0 24.9%	6,717.0 23.8%	4,090.0 12.2%
EPS	2.97	2.51	2.83	3.79	4.53	4.82	4.07	5.61	6.75	6.80	9.15	10.32	2.71	12.70	12.96	12.40	10.34	12.18	12.56	7.56
Diluted EPS	2.93	2.48	2.82	3.77	4.51	4.79	4.04	5.52	6.64	6.70	9.06	10.24	2.69	12.62	12.88	12.31	10.28	12.11	12.49	7.56
EBITDA % margin	5,689.0 45.8%	7,265.0 50.9%	5,981.0 40.5%	6,639.0 44.3%	6,580.0 44.9%	6,671.0 44.3%	5,054.0 32.4%	6,356.0 36.8%	7,391.0 39.6%	8,747.0 43.6%	11,132.0 51.4%	11,937.0 51.9%	12,804.0 56.0%	12,883.0 54.3%	12,633.0 54.1%	12,929.0 50.9%	12,542.0 48.3%	12,093.0 45.9%	14,702.0 52.2%	15,686.0 46.9%

Discover more Stock Ideas

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%

S&P Outperformance 19.1%

Next 3M Predicted Return 20.3%

Undervalued growth stocks

Discover the top 20 best undervalued large-cap growth stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 35.3%

S&P Outperformance 22.3%

Next 3M Predicted Return 26.8%

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%

S&P Outperformance 15.4%

Next 3M Predicted Return 16.9%

More ideas -->

FAQ

1) What is Amgen Inc.'s P/OCF LTM?

As of today, Microsoft Corp's last 12-month P/OCF LTM is 19.2x, based on the financial report for Dec 30, 2024 (Q4’2024). The average annual P/OCF LTM for Amgen Inc. have been 15.7x over the past three years, and 15.9x over the past five years.

2) Is Amgen Inc.'s P/OCF LTM Good?

As of today, Amgen Inc.'s P/OCF LTM is 19.2x, which is higher than industry median of 13.2x. It indicates that Amgen Inc.'s P/OCF LTM is Bad.

3) How does Amgen Inc.'s P/OCF LTM compare to its peers?

As of today, Amgen Inc.'s P/OCF LTM is 19.2x, which is higher than peer median of 16.5x. The list of peers includes LLY, PFE, AZN, ABBV, JNJ, GILD, MRK, NVS, BMY.

#Amgen Inc. P/OCF LTM

#Amgen Inc. (AMGN) P/OCF LTM comparison analysis

General

LTM P/OCF LTM

OTHER METRICS

Company name

Revenue growth

EPS growth

Net Income margin

#AMGN key stats

#Discover more Stock Ideas